“ The co-managing partner of one of Canada's leading IP law firms discusses the landscape for intellectual property in the pharmaceutical industry in Canada today, the legislative… ”
In Conversation
“ Gino Martel explains the present environment for M&As, divestitures and out-licensing in the Canadian biotech sector, the different ways that biotech companies can commercialize their scientific… ”
“ The director of Biotech City in Laval, close to Montreal, discusses the advantages brought on by the cluster effect, and how this has played out at… ”
“ The head of Lundbeck in Canada talks about the stigma of mental illness that still exists in the country today, and how CNS companies like Lundbeck… ”
“ Industry veteran and CEO of JSS Medical research explains what he thinks is going wrong with clinical research in Canada today, how Canadian CROs are losing… ”
“ As the only country in the G8 without an orphan drugs act, the President of Médunik, a company focused on bringing orphan drugs into the country,… ”
“ Calvin Tsai and Jack Wu talk about their two-pronged international approach through pharmaceuticals and nutricare. The head of the nutricare business elaborates on the challenge of… ”
“ An interesting perspective on the Canadian market, and its opportunities and challenges in drug registration on a regional level from the President of Triton Pharma, a… ”
“ The CEO of one of Denmark’s largest foundations talks about the merits of the foundation model, and the current strategies of both Lundbeck and ALK in… ”
“ The CEO of Bellus Health outlines his strategy since 2010 to change the focus of the company from Alzheimer’s to a niche disease, AA amyloidosis, as… ”
“ The CEO of MaRS Innovation, a commercialization incubator created by 16 of Toronto's best research institutions and supported by the government, assesses Toronto's merits as an… ”
“ Minister Marceau addresses the changes in policy in Quebec relating to the pharmaceutical and life sciences sectors, and the incentives in place to make the state… ”
